U.S. Stem Cell Stock Forecast, Price & News

U.S. Stem Cell (OTCMKTS:USRM) Frequently Asked Questions

How has U.S. Stem Cell's stock been impacted by COVID-19 (Coronavirus)?

U.S. Stem Cell's stock was trading at $0.0061 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, USRM stock has increased by 41.0% and is now trading at $0.0086.
View which stocks have been most impacted by COVID-19.

Are investors shorting U.S. Stem Cell?

U.S. Stem Cell saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 13,600 shares, an increase of 134.5% from the October 31st total of 5,800 shares. Based on an average trading volume of 4,046,000 shares, the days-to-cover ratio is currently 0.0 days.
View U.S. Stem Cell's Short Interest.

When is U.S. Stem Cell's next earnings date?

U.S. Stem Cell is scheduled to release its next quarterly earnings announcement on Friday, July 15th 2022.
View our earnings forecast for U.S. Stem Cell.

How were U.S. Stem Cell's earnings last quarter?

U.S. Stem Cell, Inc. (OTCMKTS:USRM) released its quarterly earnings data on Wednesday, August, 7th. The company reported $0.00 earnings per share for the quarter. The business had revenue of $1.30 million for the quarter.
View U.S. Stem Cell's earnings history.

Who are U.S. Stem Cell's key executives?

U.S. Stem Cell's management team includes the following people:

• Miguel Tomás, President, CEO, CFO & Director

Who are some of U.S. Stem Cell's key competitors?

Some companies that are related to U.S. Stem Cell include Protalex (PRTX), DNAPrint Genomics (DNAG), Affinity Energy and Health (ALGXY), Deltagen (DGEN) and Redpoint Bio (RPBC).
View all of USRM's competitors.

What other stocks do shareholders of U.S. Stem Cell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Stem Cell investors own include Orion Energy Systems (OESX), Actinium Pharmaceuticals (ATNM), Cleveland BioLabs (CBLI), Digi International (DGII), SeaChange International (SEAC), SMTC (SMTX), (APHA), (AQB), Axsome Therapeutics (AXSM) and (BGSF).

What is U.S. Stem Cell's stock symbol?

U.S. Stem Cell trades on the OTCMKTS under the ticker symbol "USRM."

How do I buy shares of U.S. Stem Cell?

Shares of USRM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Stem Cell's stock price today?

One share of USRM stock can currently be purchased for approximately $0.01.

How much money does U.S. Stem Cell make?

U.S. Stem Cell has a market capitalization of $4.33 million and generates $280 thousand in revenue each year.

How many employees does U.S. Stem Cell have?

U.S. Stem Cell employs 11 workers across the globe.

What is U.S. Stem Cell's official website?

The official website for U.S. Stem Cell is www.us-stemcell.com.

Where are U.S. Stem Cell's headquarters?

U.S. Stem Cell is headquartered at 1560 SAWGRASS CORPORATE PKWY 4TH FLOOR, SUNRISE FL, 33325.

How can I contact U.S. Stem Cell?

U.S. Stem Cell's mailing address is 1560 SAWGRASS CORPORATE PKWY 4TH FLOOR, SUNRISE FL, 33325. The company can be reached via phone at (954) 835-1500, via email at [email protected], or via fax at 954-845-9976.